Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections

To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested serum from 30 persons with breakthrough infection after 2-dose vaccination. Cross-variant neutralizing activity was comparable to that after 3-dose vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Tober-Lau, Pinkus, Gruell, Henning, Vanshylla, Kanika, Koch, Willi M., Hillus, David, Schommers, Philipp, Suárez, Isabelle, Suttorp, Norbert, Sander, Leif Erik, Klein, Florian, Kurth, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045428/
https://www.ncbi.nlm.nih.gov/pubmed/35259088
http://dx.doi.org/10.3201/eid2805.220271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045428/
https://www.ncbi.nlm.nih.gov/pubmed/35259088
http://dx.doi.org/10.3201/eid2805.220271

Ejemplares similares